Kohlberg Kravis Roberts & Co. L.P.
Kohlberg Kravis Roberts & Co. L.P. (KKR) is a leading global investment firm headquartered in New York, NY, United States. Founded in 1976 by Jerome Kohlberg Jr., Henry Kravis, and George R. Roberts, KKR manages multiple alternative asset classes such as private equity, energy, infrastructure, real estate, credit, and hedge funds. As of 2024, the firm employs over 4,450 people worldwide and is renowned for pioneering leveraged buyouts and private equity investments, serving institutional investors, governments, and corporations across the globe.
Investment Strategy
KKR's investment strategy centers around the management of alternative assets, with a primary focus on private equity, credit, infrastructure, energy, real estate, and hedge fund solutions. The firm aims to create long-term value for stakeholders by leveraging deep industry knowledge, global networks, and operational expertise. KKR uses a hands-on approach with portfolio companies and investments, pairing financial discipline with active management and strategic guidance to foster growth and performance. ESG (Environmental, Social, and Governance) considerations are integrated into its process, underscoring a commitment to sustainable investing and risk mitigation.
Latest 13F Filing Activity
Kohlberg Kravis Roberts & Co. L.P. filed their most recent 13F report on Jun 30, 2025 disclosing 13 equity positions with a total 13F market value of $5B. The fund increased holdings in Henry Schein Inc., Crescent Energy Company, Brightspring Health SVCS Inc. among other positions. Kohlberg Kravis Roberts & Co. L.P. reduced exposure to Bridgebio Pharma Inc., Brightview HLDGS Inc., KKR Real Estate Fin TR Inc. among others.
Top Holdings
Equity Positions (13)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
B BTSG | BRIGHTSPRING HEALTH SVCS INC | 37.57% | $1.82B | 77,096,338 | $11.45 | $23.59 | +$137.1M |
H HSIC | HENRY SCHEIN INC | 23.62% | $1.14B | 15,652,032 | $69.55 | $73.05 | +$320.4M |
B BBIO | BRIDGEBIO PHARMA INC | 11.83% | $572.6M | 13,260,971 | $27.37 | $43.18 | -$93.2M |
B BV | BRIGHTVIEW HLDGS INC | 7.08% | $342.7M | 21,533,123 | $21.95 | $16.65 | -$84.5M |
C CRGY | CRESCENT ENERGY COMPANY | 4.75% | $230.1M | 26,758,127 | $8.70 | $8.60 | +$223.7M |